Journal Article Summary

The article investigates the use of furosemide infusion in children suffering from dengue fever who also experience hypoxemia, a condition characterized by low oxygen levels in the blood. This topic is significant because dengue fever can lead to severe complications, including acute respiratory distress syndrome (ARDS), which can be life-threatening. Understanding effective treatments for ARDS in this population is crucial for improving patient outcomes and reducing mortality rates.

The study involved children aged 1 month to 18 years who met specific criteria for dengue infection and ARDS. Participants were divided into three groups: one receiving only diuretic therapy, another receiving both ventilation and diuretics, and a historical control group that received ventilation alone. The researchers administered furosemide at a controlled rate for 48 hours and monitored urine output. The findings indicated that the use of furosemide infusion was associated with improved survival rates and better blood gas measurements, suggesting that it may enhance outcomes for children with dengue-related ARDS.

However, the study has limitations, including a small sample size and the lack of a randomized controlled trial design, which may affect the reliability of the results. Patients and caregivers should be aware that while furosemide may improve outcomes, it is essential to discuss any treatment options with a healthcare professional. This conversation is important to ensure that all potential risks and benefits are considered, especially in the context of managing severe dengue fever and its complications.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Bharath Kumar Reddy K. R., Basavaraja G. V., Shivananda. Furosemide infusion in children with dengue fever and hypoxemia. Indian Pediatrics 2014. DOI: 10.1007/s13312-014-0398-8. PMID: 24825269. PMCID: PMC7097215.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]